Development and Validation of RP-HPLC method for Simultaneous Determination of Vildagliptin and Metformin in Bulk and Formulation Dosage

A reverse phase high performance liquid chromatographic method was developed for the simultaneous determination of Vildagliptin and Metformin in Tablet dosage form. The determination was performed by the using of two phases one is stationary phase it’s a Thermo hypersil ODS C18 column having 250 x 4.6mm 5μ, and another one is mobile phase containing 0.1M Potassium hydro phosphate and Acetonitrile at the ratio (60:40%v/v) Adjust the pH:7.0 by using Ortho phosphoric acid. The flow rate was 1ml/min and effluents were monitored at 263nm. The retention time of Metformin and Vildagliptin was 2.1min and 3.5min respectively and other replicate standard system suitability parameters are within the limit and uniform. Validation parameters those are selectivity, linearity (correlation co efficient is 1.000), recovery of Vildagliptin 99.66% and metformin 101.66 as per USP accuracy acceptance criteria is 97% to 103%, precision % RSD is less than 1 and also robustness results were uniform they were no marked changes so method is highly validated it use full for pharmaceutical analysis like Quality control , Stability and other studies.

[1]  M. Steppe,et al.  Stability-indicating RP-LC method for the determination of vildagliptin and mass spectrometry detection for a main degradation product. , 2012, Journal of chromatographic science.

[2]  P. K. Choudhury,et al.  HPLC Method for Estimation of Metformin Hydrochloride in Formulated Microspheres and Tablet Dosage Form , 2009, Indian journal of pharmaceutical sciences.

[3]  V. Fischer,et al.  Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans , 2009, Drug Metabolism and Disposition.

[4]  Colleen D Lauster,et al.  Vildagliptin: a novel oral therapy for type 2 diabetes mellitus. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[5]  H. Aboul‐Enein,et al.  Simultaneous Determination of Metformin and Glyburide in Tablets by HPTLC , 2006 .

[6]  R. Pederson,et al.  Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents? , 2005, Regulatory Peptides.

[7]  K. D. Tripathi,et al.  Essentials of Medical Pharmacology , 2004 .

[8]  A. Weber Dipeptidyl peptidase IV inhibitors for the treatment of diabetes. , 2004, Journal of medicinal chemistry.

[9]  Xiaoyan Chen,et al.  Rapid determination of metformin in human plasma by liquid chromatography-tandem mass spectrometry method. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  O. Ali,et al.  Hypoglycemic potential of tablet Metformin 500 mg (Glucophage & Metphage): a pharmacological end point evaluation. , 2003, Pakistan Journal of Pharmaceutical Sciences.

[11]  C. Seervi,et al.  Simultaneous UV Spectrophotometric Method for Estimation of Gliclazide and Metformine Hydrochloride in Tablet Dosage Form , 2003 .